Investment
Features
FeesSafety
Academy
More
Pluang+

Brixmor to present at BofA Securities 2026 Global Real Estate Conference on Sept 15

Market News
03 Sep 2026
PRNewsWire
View Source
Neutral
pluang ai news

Brixmor Property Group announced it will present at the BofA Securities 2026 Global Real Estate Conference on September 15, 2026. The presentation will be webcast live and available for replay until September 15, 2027. Brixmor owns and operates 346 open-air shopping centers across the U.S., totaling about 63 million square feet of retail space. This event provides investors insight into Brixmor's business outlook and strategy amid various market risks and opportunities.

More News

Hutchison China MediTech upgraded to Buy after $1.3B GSK licensing deal for cancer drug.

Hutchison China MediTech upgraded to Buy after $1.3B GSK licensing deal for cancer drug.

Hutchison China MediTech Limited (HCM) received a Buy rating upgrade from Daiwa with a new price target of $18.50 following a major licensing deal with GSK. The agreement grants GSK exclusive rights to commercialize HCM's experimental cancer therapy ...

Analyst Insights
Bullish
2 hours ago
Duluth Holdings beats Q2 EPS estimates with $0.50, driven by tariff refunds and strategic product focus.

Duluth Holdings beats Q2 EPS estimates with $0.50, driven by tariff refunds and strategic product focus.

Duluth Holdings reported a strong Q2 earnings per share (EPS) of $0.50, far exceeding the consensus estimate of -$0.01, largely due to $0.44 per share from tariff refunds. Revenue reached $121.39 million, beating estimates but declining from the prev...

Company Fundamentals
Bullish
2 hours ago
Estée Lauder announces leadership changes amid insider stock sale and high valuation metrics.

Estée Lauder announces leadership changes amid insider stock sale and high valuation metrics.

Estée Lauder Companies recently appointed new brand leaders, signaling strategic shifts in its competitive beauty market. An insider executive sold 7,766 shares worth over $802,000, leaving no remaining holdings. The company shows a high P/E ratio of...

Market News
Neutral
2 hours ago
HUTCHMED stock jumps 17.8% on $1.3B GSK licensing deal for cancer therapy

HUTCHMED stock jumps 17.8% on $1.3B GSK licensing deal for cancer therapy

HUTCHMED's shares surged 17.77% after announcing a major licensing deal with GSK for its preclinical cancer drug HMPL-A830. GSK gets exclusive rights outside Greater China, paying $110 million upfront plus up to $1.295 billion in milestone payments. ...

Market News
Bullish
3 hours ago
Genesco beats Q2 earnings estimates despite retail challenges, improving profitability and managing expenses well.

Genesco beats Q2 earnings estimates despite retail challenges, improving profitability and managing expenses well.

Genesco reported second-quarter earnings that surpassed analyst expectations, with an EPS loss of $0.83 versus the estimated loss of $1.37 per share. Although revenue fell 3% year-over-year to $529.86 million, the company improved its adjusted gross ...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App